Tom Wilder

Tom Wilder is a highly experienced professional with a diverse background in the medical device industry. Tom currently serves as President & CEO at Neuros Medical, Inc. and as an Advisory Board Member at Vensana Capital.

Prior to their current roles, Tom has held various leadership positions throughout their career. Notably, they served as a Member of the Board of Directors at Penumbra, Inc., where they contributed to the company's success in developing innovative medical devices. Additionally, they were the President & Chief Executive Officer at Sequent Medical, Inc., a company that developed a novel treatment for cerebral aneurysms before being acquired by Terumo.

Tom's expertise in the medical device industry extends further back in their career. Tom served as the President & Chief Executive Officer at both PhotoThera, Inc. and MicroTherapeutics, Inc., where they played pivotal roles in developing and commercializing advanced interventional products. Prior to that, they held various management positions at Medtronic, Inc., where they gained extensive experience in areas such as finance, business development, and general management.

Before entering the medical device industry, Tom began their career at PwC, where they held various positions over a three-year period.

Overall, Tom Wilder's extensive work experience showcases their strong leadership and expertise in the medical device industry, particularly in the development and commercialization of innovative medical devices.

Tom Wilder attended Air Academy High School, but it is unclear when they started and completed their studies there. Following high school, they went on to Stanford University from 1982 to 1986, where they earned their Bachelor of Arts degree in Economics. Later, from 1989 to 1991, Tom attended Northwestern University - Kellogg School of Management, where they obtained their Master of Business Administration (MBA) degree. No specific field of study is mentioned for their MBA.